The Huang Lab was awarded an American Cancer Society EDS Accelerator Grant to support the preclinical development of PH102 for hepatocellular carcinoma.

The award strengthens the lab’s translational pipeline and supports the next phase of work needed to move this program toward broader development.

More news

Related updates